Lex Witness announces 12th Annual Pharmaceutical Legal & Compliance Summit 2026

Like previous editions, the Summit will focus on practical perspectives, peer learning and candid dialogue rather than conventional conference-style discussions.

Lex Witness is set to host the 12th Annual Pharmaceutical Legal & Compliance Summit 2026 on Friday, October 9, 2026 at Taj Santacruz, Mumbai, bringing together some of the most prominent voices from India’s pharmaceutical, life sciences, legal and compliance ecosystem.

Now in its 12th year, the Summit has grown into a specialised industry platform for General Counsels, Chief Legal Officers, Heads of Legal, Compliance and Regulatory Affairs, senior corporate leaders, law firm partners and subject-matter experts to engage on the legal and regulatory issues directly impacting the pharmaceutical and life sciences sector. Express Pharma is a media partner for this year’s Summit.

The 2026 edition will feature practitioner-led conversations around the evolving regulatory and compliance environment, governance and enforcement, intellectual property, technology and data, contracting, investigations, disputes and emerging business risks. The emphasis will remain on practical perspectives, peer learning and candid dialogue rather than conventional conference-style discussions.

Commenting on the journey of the Summit, Bhupinder Kaur Minhas, Sr. Manager Brand Innovation, Lex Witness, said,“When we began building this platform 12 years ago, the idea was to create a dedicated space where the pharmaceutical sector’s legal, regulatory, IPR and compliance leadership could have conversations that were relevant to their businesses. Over the years, we have consciously built the summit around the community – listening to the issues that matter to them, bringing the right voices into the room and allowing the dialogue to evolve with the sector. It is extremely rewarding to see it emerge as one of the preferred legal dialogues for the pharmaceutical, healthcare, medtech and life sciences industry, and the 12th Annual Edition is about taking that engagement even further.”

With limited seats available for the invitation-led gathering, registrations are now open. Early Bird and Group Registration benefits of up to 25 per cent are currently available for eligible registrations.

Lex Witness is also inviting speaking interests from senior legal, compliance, regulatory, business and domain leaders who can contribute meaningfully to the Summit’s conversations. Organisations looking to engage with this focused community can also explore a limited number of sponsorship and partnership opportunities for the 12th Annual Edition.

The Summit will combine high-quality content with curated networking, enabling participants to exchange perspectives with peers and build meaningful connections across the pharmaceutical and life sciences legal ecosystem.

For participation opportunities, visit www.plcs.co.in

Lex WITNESSPharmaceutical Legal & Compliance Summit 2026
Comments (0)
Add Comment